We discovered a lot about the company and both the convenience and limitations of third-party compounding pharmacies to provide certain goods
Sanjay Kaul, a frequent FDA advisor, pointed out the paradox of the large commercial success of the diabetes drugs despite the absence of any proven clinical benefit: "So, we have a drug that yields modest glycemic efficacy, is neutral with respect to cardiometabolic factors (lipids, weight, blood pressure), does not kill you or land you in a hospital, and yet is a blockbuster drug nearly 5 times over
According to analysis by industry observers, vendors operating with these practices faced an estimated 85% lower probability of regulatory action compared to vendors with marketing-forward approaches and limited quality documentation
Patient assistance programs: Novo Nordisks patient assistance program, NovoCare, offers free Ozempic to eligible patients with type 2 diabetes